Experts Categorize Policy Options For Drug Pricing Legislation

By Gabrielle Wanneh / September 9, 2021 at 2:42 PM
The University of Southern California and the Brookings Institution categorized the main policy issues for lawmakers writing drug pricing legislation, including whether the government or an outside group should negotiate prices, which drugs to target, who gets those prices, how to assess value and what to do when negotiations fail. Democrats plan to direct Medicare to negotiate drug prices in their budget reconciliation bill, and the Brookings analysis is meant to help conceptualize the big questions facing lawmakers. What happens...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.